Working together for a healthier world®
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more, please visit us at www.pfizer.com.
MISSION BAY CAPITAL
Mission Bay Capital is an independent venture firm focused on making pivotal, early-stage investments in bioscience companies emerging from the University of California. Founded in June 2009, Mission Bay Capital combines the rich knowledge and navigation skills of QB3 executives—Regis Kelly, Douglas Crawford, and Neena Kadaba—with the experience and proven success of a renowned investment advisory committee led by Brook Byers and John Wadsworth. Mission Bay Capital is fueling breakthrough bioscience technologies to meet society’s challenges while also helping to boost the California economy.
SHANGPHARMA INVESTMENT GROUP, LIMITED
With the mission of providing and developing cutting edge science and technology to help its partners develop important new therapies, the ShangPharma Group includes divisions wholly focused on enabling new technologies ('ShangPharma Technologies') and investing in early stage ideas ('ShangPharma Investments') that provide the innovative foundations for future drug therapies.